EUVIMEDEUVIMED entdecken
Editorial

Psychosis Risk With Prescription Amphetamine

Carol A Tamminga

American Journal of Psychiatry · 2024

DOI: 10.1176/appi.ajp.20240732 ↗

Kurz gefasst

Editorial in der Zeitschrift American Journal of Psychiatry, 2024. Verfasst von Carol A Tamminga. Beteiligte Einrichtung: Department of Psychiatry, UT Southwestern Medical Center, Dallas. Hauptthemen laut MEDLINE: Amphetamine, Amphetamine-Related Disorders, Psychoses, Substance-Induced, Prescription Drugs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmphetamineAmphetamine-Related DisordersPsychoses, Substance-InducedPrescription DrugsHumansCentral Nervous System StimulantsPsychotic DisordersRisk Factors

Stichwörter der Autor:innen

AmphetaminesPsychopharmacologyPsychosisSchizophrenia Spectrum and Other Psychotic Disorders

Substanzen

AmphetamineCentral Nervous System StimulantsPrescription Drugs

Autor:innen und Institutionen

  • Department of Psychiatry, UT Southwestern Medical Center, Dallas.

Zitieren

APA

Tamminga, C. A. (2024). Psychosis Risk With Prescription Amphetamine. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.20240732

Vancouver

Tamminga CA. Psychosis Risk With Prescription Amphetamine. American Journal of Psychiatry. 2024. doi:10.1176/appi.ajp.20240732

BibTeX
@article{Tamminga2024,
  author = {Tamminga, Carol A},
  title = {Psychosis Risk With Prescription Amphetamine},
  journal = {American Journal of Psychiatry},
  year = {2024},
  doi = {10.1176/appi.ajp.20240732}
}
Kostenlos starten →